Pulse oximeter devices routinely overestimate blood oxygen levels in darker-skinned patients—a racial bias that can trigger downstream health harms for Black individuals, compounding well beyond any ...

It's safe to assume at this point that the next generation of Apple Watches might not look dramatically different on the outside, but a fresh rumour suggests one of the wearable’s most controversial ...

An announcement from Masimo ( (MASI)) is now available. On May 1, 2026, Masimo shareholders approved the company’s merger agreement with Danaher Corporation at a virtual special meeting, with roughly ...

Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to ...

These promising results—from an NIH-funded study that exclusively evaluated Masimo SET ® in a vulnerable, clinically fragile patient population—add to previously published evidence of its strong ...

Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...

NICU Study Adds to the Evidence Demonstrating SET®’s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation Categories or Race ...

Masimo Corp. today reported study data showing that its pulse oximetry technology accurately monitored hospitalized newborns of all skin tones without dangerous drops in blood oxygen. The findings ...

Apple can keep selling Apple Watches with its redesigned blood oxygen feature in the US after the ITC declined to revive Masimo’s ban.